Cargando…

Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries

BACKGROUND: Triple-negative breast cancer (TNBC) has been demonstrated to carry poor prognosis, but whether or not there exists any age-related variation in TNBC outcomes has yet to be elucidated. The current population-based study investigated the early survival pattern of elderly women with TNBC a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Wenjie, Perez, Edith A., Hong, Ruoxi, Li, Qing, Xu, Binghe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447406/ https://www.ncbi.nlm.nih.gov/pubmed/26020519 http://dx.doi.org/10.1371/journal.pone.0128345

Ejemplares similares

Survival Outcome and Impact of Chemotherapy in T1 Node-Negative Triple-Negative Breast Cancer: A SEER Database Analysis
por: Zhang, Jingyi, et al.
Publicado: (2020)

A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
por: Ma, Fei, et al.
Publicado: (2014)

Outcomes of Immediate Breast Reconstruction in Triple Negative Breast Cancer
por: Grigor, Emma, et al.
Publicado: (2021)

The Demographic Features, Clinicopathological Characteristics and Cancer-specific Outcomes for Patients with Microinvasive Breast Cancer: A SEER Database Analysis
por: Wang, Wenna, et al.
Publicado: (2017)

Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011–2019 NPCR and SEER incidence data
por: Zhang, Wei, et al.
Publicado: (2022)

Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer
por: Han, Yiqun, et al.
Publicado: (2023)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer
por: Zhu, Anjie, et al.
Publicado: (2016)

Treatment options for patients with triple-negative breast cancer
por: Santana-Davila, Rafael, et al.
Publicado: (2010)

Racial disparities in health insurance, triple-negative breast cancer diagnosis, tumor stage, treatment and survival in a large nationwide SEER cohort in the United States
por: Du, Xianglin
Publicado: (2022)

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries
por: Berrington de Gonzalez, A, et al.
Publicado: (2010)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy
por: Li, Zhijun, et al.
Publicado: (2023)

Geographic and intra‐racial disparities in early‐onset colorectal cancer in the SEER 18 registries of the United States
por: Abualkhair, Wesal H., et al.
Publicado: (2020)

Breast cancer: an up‐to‐date review and future perspectives
por: Hong, Ruoxi, et al.
Publicado: (2022)

Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancer
por: Han, Yiqun, et al.
Publicado: (2021)

Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data
por: Wieder, Robert, et al.
Publicado: (2023)

Update on triple-negative breast cancer: prognosis and management strategies
por: Brouckaert, Olivier, et al.
Publicado: (2012)

A single-nucleotide polymorphism in the 3′-UTR region of the adipocyte fatty acid binding protein 4 gene is associated with prognosis of triple-negative breast cancer
por: Wang, Wenmiao, et al.
Publicado: (2016)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities
por: Hong, Ruoxi, et al.
Publicado: (2015)

The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database
por: Chen, Qing-Xia, et al.
Publicado: (2016)

Factors associated with late risks of breast cancer-specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021)

Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer
por: Fan, Ying, et al.
Publicado: (2015)

YB1 Is a Major Contributor to Health Disparities in Triple Negative Breast Cancer
por: Rana, Priyanka Shailendra, et al.
Publicado: (2021)

Racial disparities in triple negative breast cancer: toward a causal architecture approach
por: Siegel, Scott D., et al.
Publicado: (2022)

Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits
por: Wang, Biyuan, et al.
Publicado: (2021)

Use of Mastectomy for Overdiagnosed Breast Cancer in the United States: Analysis of the SEER 9 Cancer Registries
por: Harding, C., et al.
Publicado: (2019)

PRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer
por: Guo, Fengzhu, et al.
Publicado: (2023)

The role of BRCA status on prognosis in patients with triple-negative breast cancer
por: Xie, Yuxin, et al.
Publicado: (2017)

Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
por: Pogoda, Katarzyna, et al.
Publicado: (2020)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

Impact of Triple-Negative Breast Cancer Phenotype on Prognosis in Patients with Stage I Breast Cancer
por: Kim, Jeong Eun, et al.
Publicado: (2012)

Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry
por: Mattes, Malcolm D., et al.
Publicado: (2015)

Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021)

A phase Ib study of TQB2450 plus anlotinib in patients with advanced triple-negative breast cancer
por: Wang, Jiayu, et al.
Publicado: (2023)

Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis
por: Vyas, Ami, et al.
Publicado: (2021)

Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
por: Schreiber, Anna R., et al.
Publicado: (2021)

The relationship between immediate postmastectomy reconstruction modalities and survival benefits in patients with triple negative breast cancer
por: Dai, Luyao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_joo0fu4rldobogdos6hl60a3gg